SCHEMBL164426

SCHEMBL164426

Cc1ccc(C(N)=O)c(C)c1C(=O)NCc1ccccn1

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.55
ALDH1A1 P00352 2/20 0.55
CYP1A2 P05177 1/20 0.55
POLB P06746 1/20 0.54
HPGD P15428 4/20 0.54
RAB9A P51151 3/20 0.54
KDM4E B2RXH2 1/20 0.54
SMN1; SMN2 Q16637 2/20 0.50
LMNA P02545 2/20 0.50
GAA P10253 2/20 0.50
NPC1 O15118 1/20 0.50
MAPT P10636 1/20 0.50
ALOX15 P16050 1/20 0.49
HTT P42858 1/20 0.49
ADORA2A P29274 1/20 0.48
ADORA1 P30542 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL164424 0.90 HPGD (0.57) L3MBTL1ALDH1A1CYP1A2POLBHPGD
SCHEMBL166870 0.89 ALDH1A1 (0.56) L3MBTL1ALDH1A1CYP1A2POLBHPGD
SCHEMBL6651573 0.79 SMN1; SMN2 (0.49) ALDH1A1POLBRAB9AKDM4ESMN1; SMN2
SCHEMBL13534520 0.78 HPGD (0.63) L3MBTL1ALDH1A1CYP1A2POLBHPGD
SCHEMBL5321616 0.76 HPGD (0.69) L3MBTL1ALDH1A1CYP1A2POLBHPGD
SCHEMBL27680048 0.76 HPGD (0.64) L3MBTL1ALDH1A1CYP1A2POLBHPGD
SCHEMBL29451525 0.75 NPC1 (0.60) L3MBTL1ALDH1A1CYP1A2HPGDRAB9A
SCHEMBL27737857 0.75 HPGD (0.62) L3MBTL1ALDH1A1CYP1A2POLBHPGD
SCHEMBL166268 0.75 RAB9A (0.54) ALDH1A1POLBRAB9ASMN1; SMN2NPC1
SCHEMBL28310420 0.73 LMNA (0.74) L3MBTL1ALDH1A1POLBHPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed